VALENCIA, Calif. , April 28 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Morgan Stanley Healthcare Conference on Wednesday, April 30, 2008 at 8:30 AM ET at The Ritz-Carlton, Key Biscayne, Florida .

Interested parties can access a link to the live web cast of the presentation in the Investor Relations section of the Company's website at www.mannkindcorp.com. A replay of each presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States , Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit www.mannkindcorp.com.

SOURCE MannKind Corporation